In a retrospective study that investigated the effects of statins on overall survival of patients with a diagnosis of colon cancer in the Netherlands, statin use was associated with a 34% reduction in colorectal cancer death in the subset of patients with bone morphogenetic protein (BMP) signaling irrespective of their KRAS status [28]. Here, KRAS is linked to malignant colon neoplasm.